ARTICLE | Clinical News
Rapiacta peramivir regulatory update
October 4, 2010 7:00 AM UTC
BioCryst said partner Shionogi has received recommendation for approval by Japan's Ministry of Health, Labor and Welfare (MHLW) for pediatric use of Rapiacta peramivir to treat influenza. Rapiacta is ...